SCHEMBL2806091

SCHEMBL2806091

O=C(O)CCCNC(=O)CCC(=O)NCCCC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.57
PRMT1 Q99873 1/20 0.56
ADRA1A P35348 1/20 0.52
LMNA P02545 3/20 0.52
TSHR P16473 2/20 0.52
MEN1 O00255 1/20 0.51
MAPT P10636 1/20 0.51
KMT2A Q03164 1/20 0.51
SLC6A5 Q9Y345 1/20 0.51
EPHX2 P34913 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
KDM4E B2RXH2 1/20 0.50
ECE1 P42892 1/20 0.48
NFKB1 P19838 1/20 0.48
PMP22 Q01453 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30410272 0.97 ATM (0.55) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL12999626 0.97 ATM (0.55) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL9717385 0.92 TSHR (0.59) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL2811862 0.92 PRMT1 (0.60) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL31317640 0.90 PRMT1 (0.64) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL31317706 0.90 PRMT1 (0.64) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL16620647 0.90 PRMT1 (0.64) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL31317673 0.90 PRMT1 (0.64) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL9717419 0.90 ECE1 (0.60) ATMPRMT1ADRA1ALMNATSHR
SCHEMBL6812011 0.90 PRMT1 (0.56) PRMT1ADRA1ALMNATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
WO-2025011640-A1 MEMANTINE DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广州市恒诺康医药科技有限公司 2025-01-16 WO disclosed
EP-4204100-A1 HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE L'OREAL (FR) 2023-07-05 EP disclosed
CN-116322616-A Hair lightening compositions providing damage protection and sensory benefits and methods of use 欧莱雅 2023-06-23 CN disclosed
US-11559474-B2 Hair lightening compositions and methods of use L'OREAL (FR) 2023-01-24 US disclosed
WO-2022047081-A1 HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE HENRY DEREK (US) 2022-03-03 WO disclosed
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US disclosed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US disclosed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US disclosed
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION L'OREAL (FR) 2009-01-29 US disclosed
US-5086104-A Mixture of thermoplastic resin, elastomer and amide compound, excellent toughtness, heat resistance and durability POLYPLASTICS CO., LTD. (JP) 1992-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 ATM 1985/4885PRMT1 4663/4885ADRA1A 4844/4885
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION CUTA, SYMPK, TPRKB ATM 1646/4885PRMT1 2654/4885ADRA1A 4879/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA ATM 928/4885PRMT1 2072/4885ADRA1A 4380/4885
US-11559474-B2 Hair lightening compositions and methods of use TYR, ALAD, CYBA ATM 3868/4885PRMT1 1066/4885ADRA1A 4779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.